Risk of Gynaecological Cancers as Second Primary in Non-gynaecological Cancer Survivors: A Retrospective Cohort Study

N R Sindhu; Dhanya Susan Thomas; Ajit Sebastian; Anitha Thomas; Rachel Chandy; Sherin Daniel; Vinotha Thomas

doi:10.1007/s13224-024-02041-0

Risk of Gynaecological Cancers as Second Primary in Non-gynaecological Cancer Survivors: A Retrospective Cohort Study

J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):146-151. doi: 10.1007/s13224-024-02041-0. Epub 2024 Aug 29.

Authors

N R Sindhu¹, Dhanya Susan Thomas¹, Ajit Sebastian¹, Anitha Thomas¹, Rachel Chandy¹, Sherin Daniel², Vinotha Thomas¹

Affiliations

¹ Department of Gynaecologic Oncology, Christian Medical College and Hospital, Vellore, Tamil Nadu India.
² Department of Pathology, Christian Medical College, Vellore, Tamil Nadu India.

PMID: 40390889
PMCID: PMC12085543 (available on 2026-04-01)
DOI: 10.1007/s13224-024-02041-0

Abstract

Aims and objectives: This study aims to explore the clinical-pathological profile of gynaecological malignancies occurring as a second cancer and identify their modifiable and non-modifiable risk factors.

Methodology: This retrospective cohort study included women operated for gynaecological carcinoma following a previous treated malignancy, in the gynaecologic oncology department of a tertiary care hospital, between 1st January 2016 and 31st December 2021. Demographic details, clinical and pathological characteristics of the current malignancy and previous malignancy were obtained from medical records and analysed using descriptive statistics.

Results: During this period, 2370 women with gynaecological malignancies were operated, of whom 27 (1.1%) patients had gynaecological malignancy as a second malignancy. This included 19 (70.3%) endometrial and 8 (29.6%) ovarian cancer patients following a median period of 48 (24-144 months) from the index malignancy. Their median age and BMI were 60 years (37-67) and 27 (17-39.1), respectively. Endometrioid endometrial cancer was most common and was preceded by breast carcinoma in 19 (70.37%) and colorectal in 5 (18.5%). Four patients had previous microsatellite unstable colorectal cancer. Two patients were found to have mismatch repair deficient endometrial cancer on somatic testing. High-grade serous carcinoma was the most common ovarian histology and was preceded by breast cancer in 6 (75%). Four patients underwent germline testing, and one was found to have a (breast cancer gene) BRCA pathogenic mutation.

Conclusion: Breast cancer and colon cancer can precede gynaecologic cancer. Individualization of somatic and genetic testing in colorectal and breast cancers will allow screening and prevention of second gynaecologic malignancies.

Keywords: Endometrial carcinoma; Gynaecological malignancies; Ovarian carcinoma; Second primary malignancy.

© Federation of Obstetric & Gynecological Societies of India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.